|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/497 | |
| A61K 31/5513 | |||
| C07D 215/36 | |||
| C07D 215/40 | |||
| C07D 239/42 | |||
| C07D 241/20 | |||
| C07D 243/08 | |||
| C07D 271/12 | |||
| C07D 277/64 | |||
| C07D 277/68 | |||
| C07D 319/18 | |||
| C07D 401/12 | |||
| C07D 401/14 | |||
| C07D 403/12 | |||
| C07D 407/12 | |||
| C07D 409/12 | |||
| C07D 417/12 | |||
| C07D 417/14 | |||
| C07D 295/192 | |||
| A61P 35/00 |
| (11) | Number of the document | 3241554 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17000407.1 |
| Date of filing the European patent application | 2010-06-29 | |
| (97) | Date of publication of the European application | 2017-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 221430 P | 2009-06-29 | US | |
| 292360 P | 2010-01-05 | US |
| (72) |
Saunders, Jeffrey O., US
Salituro, Francesco G., US
Yan, Shunqi, US
|
| (73) |
Agios Pharmaceuticals, Inc.,
88 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY |
| QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY |